Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GGHCX vs. LYFIX: which is better?

Bottom line

GGHCX vs LYFIX: the short answer

GGHCX (INVESCO Health Care Fund) and LYFIX (AlphaCentric Life Sciences and Healthcare Fund) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.

GGHCX is cheaper at 1.07% vs 1.41% — a difference of $34 a year per $10,000 invested.

Over five years, LYFIX returned +5.6% a year vs +2.6% for GGHCX.

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

GGHCX vs LYFIX side by side

GGHCXLYFIX
TypeMutual fundMutual fund
Fund familyInvescoMutual
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.07%1.41%
Annual cost per $10k$107$141
10-yr cost on $10k (prospectus)$1,784$2,357
Max front load5.5%0%
12b-1 fee0.25%0%
1-yr return+9.2%+28.2%
5-yr return (annualized)+2.6%+5.6%
10-yr return (annualized)+5.8%—
Best quarter+19.6%+27.5%
Worst quarter−16.5%−11.9%
Net assets (fund)$1.2B$46.6M
Number of holdings8262
Portfolio turnover59%107%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

5 of GGHCX's top 25 holdings also appear in LYFIX's top 25.

Shared top holdings
HoldingGGHCXLYFIX
AbbVie Inc.4.03%1.95%
Gilead Sciences, Inc.3.63%5.53%
argenx SE3.24%3.59%
Vertex Pharmaceuticals Inc.2.01%5.33%
Axsome Therapeutics, Inc.1.58%3.43%

Source: SEC Form N-PORT

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

LYFIX top 10

  1. Gilead Sciences Inc — 5.53%
  2. Vertex Pharmaceuticals Inc — 5.33%
  3. Astrazeneca Plc — 4.63%
  4. First American Funds Inc — 4.26%
  5. Roivant Sciences Ltd — 3.67%
  6. Argenx Se — 3.59%
  7. Neurocrine Biosciences Inc — 3.51%
  8. Incyte Corp — 3.51%
  9. Axsome Therapeutics Inc — 3.43%
  10. Apogee Therapeutics Inc — 3.28%

FAQ

What is the difference between GGHCX and LYFIX?
GGHCX (INVESCO Health Care Fund) and LYFIX (AlphaCentric Life Sciences and Healthcare Fund) are quite different portfolios: only about 17% of their top holdings (by weight) are shared. GGHCX is cheaper at 1.07% vs 1.41% — a difference of $34 a year per $10,000 invested.
Which is cheaper, GGHCX or LYFIX?
GGHCX has the lower expense ratio (1.07%).
Should I own both GGHCX and LYFIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.